Amity D Helzer, MMS, PA-C | |
3550 Lutheran Pkwy Ste 100a, Wheat Ridge, CO 80033-6013 | |
(303) 403-7333 | |
(303) 403-7335 |
Full Name | Amity D Helzer |
---|---|
Gender | Female |
Speciality | Physician Assistant |
Experience | 23 Years |
Location | 3550 Lutheran Pkwy Ste 100a, Wheat Ridge, Colorado |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1013069566 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
363AM0700X | Physician Assistant - Medical | 1541 (Colorado) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Lutheran Medical Center | Wheat ridge, CO | Hospital |
Platte Valley Medical Center | Brighton, CO | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Platte Valley Medical Group Llc | 5890054100 | 75 |
Cancer Centers Of Colorado, Llc | 8022376128 | 2 |
News Archive
In humans, cholera is among the world's most deadly diseases, killing as many as 140,000 persons a year, according to World Health Organization statistics. But in aquatic environments far away from humans, the same bacterium attacks neighboring microbes with a toxic spear - and often steals DNA from other microorganisms to expand its own capabilities.
Scientists at Rutgers and Stanford universities have created a new technology that could someday help treat Parkinson's disease and other devastating brain-related conditions that affect millions of people.
Mayo Clinic researchers, as part of a nine-site study, helped discover the best of three currently-used treatments for convergence insufficiency in children. Convergence refers to the natural ability of the eyes to focus and align while viewing objects up close.
Viralytics Limited announced today that it has entered into a clinical trial collaboration agreement through subsidiaries of Merck & Co., Inc., Kenilworth, New Jersey, U.S.A. (known as MSD outside the United States and Canada) to evaluate the combination of Viralytics' investigational cancer immunotherapy CAVATAK, with MSD's KEYTRUDA, an anti-PD-1 (programmed death receptor-1) therapy.
Seattle Genetics, Inc. today announced that it has entered into a new antibody-drug conjugate (ADC) collaboration with Bayer HealthCare (Bayer). Under the latest relationship, Bayer will pay upfront and option exercise fees of up to $20 million for worldwide rights to utilize Seattle Genetics' auristatin-based ADC technology with antibodies to several oncology targets.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Amity D Helzer, MMS, PA-C 3550 Lutheran Pkwy Ste 100a, Wheat Ridge, CO 80033-6013 Ph: (303) 403-7333 | Amity D Helzer, MMS, PA-C 3550 Lutheran Pkwy Ste 100a, Wheat Ridge, CO 80033-6013 Ph: (303) 403-7333 |
News Archive
In humans, cholera is among the world's most deadly diseases, killing as many as 140,000 persons a year, according to World Health Organization statistics. But in aquatic environments far away from humans, the same bacterium attacks neighboring microbes with a toxic spear - and often steals DNA from other microorganisms to expand its own capabilities.
Scientists at Rutgers and Stanford universities have created a new technology that could someday help treat Parkinson's disease and other devastating brain-related conditions that affect millions of people.
Mayo Clinic researchers, as part of a nine-site study, helped discover the best of three currently-used treatments for convergence insufficiency in children. Convergence refers to the natural ability of the eyes to focus and align while viewing objects up close.
Viralytics Limited announced today that it has entered into a clinical trial collaboration agreement through subsidiaries of Merck & Co., Inc., Kenilworth, New Jersey, U.S.A. (known as MSD outside the United States and Canada) to evaluate the combination of Viralytics' investigational cancer immunotherapy CAVATAK, with MSD's KEYTRUDA, an anti-PD-1 (programmed death receptor-1) therapy.
Seattle Genetics, Inc. today announced that it has entered into a new antibody-drug conjugate (ADC) collaboration with Bayer HealthCare (Bayer). Under the latest relationship, Bayer will pay upfront and option exercise fees of up to $20 million for worldwide rights to utilize Seattle Genetics' auristatin-based ADC technology with antibodies to several oncology targets.
› Verified 7 days ago
Ms. Ashley Reed Schermerhorn, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 3455 Lutheran Pkwy, Suite 290, Wheat Ridge, CO 80033 Phone: 303-467-1400 Fax: 303-467-1467 | |
Mr. Simon Louis Edwards, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 8300 W 38th Ave, Wheat Ridge, CO 80033 Phone: 303-425-2525 | |
Stephanie Missey Rozier, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 7495 W 29th Ave, Wheat Ridge, CO 80033 Phone: 303-239-9964 Fax: 303-237-4343 | |
Brielle Smith, PA-C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 3555 Lutheran Pkwy, Suite 340, Wheat Ridge, CO 80033 Phone: 303-996-6005 | |
Scott Marcel Lepage, PA-C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 3555 Lutheran Pkwy Ste 360, Wheat Ridge, CO 80033 Phone: 303-431-5280 Fax: 303-422-2002 | |
Mrs. Kristen E Walden, P.A. Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 4803 Ward Rd, Wheat Ridge, CO 80033 Phone: 303-338-4545 |